Genmab A/S/ DK0010272202 /
3/23/2023 4:59:45 PM | Chg. +23.50 | Volume | Bid4:59:45 PM | Ask4:59:45 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2,550.00DKK | +0.93% | 65,263 Turnover: 57.86 mill. |
-Bid Size: - | -Ask Size: - | 167.58 bill.DKK | - | 55.43 |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 46.00 DKK | -36.99% |
EPS Diluted: | 45.54 DKK | -36.93% |
Revenues per Share: | 129.07 DKK | -16.33% |
Book Value per Share: | 337.75 DKK | 15.78% |
Cash Flow per Share: | 33.90 DKK | -65.46% |
Dividend per Share: | - DKK | - |
Total | in mill. | |
Revenues: | 8,482.00 DKK | -16.11% |
Net Income: | 3,008.00 DKK | -36.78% |
Operating Cash Flow: | 2,228.00 DKK | - |
Cash and Cash Equivalents: | 8,957.00 DKK | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 55.43 | 57.17 |
P/S Ratio: | 19.76 | 20.38 |
P/BV ratio: | 7.55 | 7.79 |
P/CF Ratio: | 75.22 | 77.58 |
PEG: | -1.50 | -1.55 |
Earnings Yield: | 1.80% | 1.75% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 167.58 bill. DKK | 172.84 bill. DKK |
Free Float Market Cap.: | 159.2 bill. DKK | 164.2 bill. DKK |
Market Cap. / Employee: | 138.27 mill. DKK | 142.61 mill. DKK |
Shares Outstanding: | 65.72 mill. |
Profitability
Gross Profit Margin: | 100.00% |
EBIT Margin: | 35.58% |
Net Profit Margin: | 35.46% |
Return on Equity: | 13.55% |
Return on Assets: | 12.21% |
Financial Strength
Liquidity I / Cash Ratio: | 571.24% |
Liquidity II / Quick Ratio: | 571.24% |
Liquidity III / Current Ratio: | 1,450.00% |
Debt / Equity Ratio: | 10.95% |
Dynam. Debt / Equity Ratio: | 109.11% |
Efficiency
Employees: | 1,212 |
Personal Expenses / Employee: | - DKK |
Revenues / Employee: | 6,998,349.84 DKK |
Net Income / Employee: | 2,481,848.18 DKK |
Total Assets / Employee: | 20,319,306.93 DKK |
* Fiscal Year End: | 12/31/2021 |
Accounting Standard: | IFRS |
Currency: | DKK |